Sharps Compliance To Present at ROTH Virtual London Conference

HOUSTON, June 16, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive Officer, will participate in the ROTH Virtual London Conference on Tuesday, June 22, 2021.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Wednesday, June 16, 2021

Information

Tags:

Medical waste, Biological hazards, Medical ethics, Biological waste, Biomedical waste, Biology, Sharps waste, Sharps, Articles, SMED, Pharmacy, Nature

Geotags:

Houston, TX, Us, TEXAS

Organisation:

SHARPS COMPLIANCE CORP.

Summary

Key Points:

HOUSTON, June 16, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive Officer, will participate in the ROTH Virtual London Conference on Tuesday, June 22, 2021.
He will conduct one-on-one meetings throughout the day.
Headquartered in Houston, Texas, Sharps Compliance (NASDAQ: SMED) is a leading business-to-business services provider to the healthcare, long-term care and retail pharmacy markets.
Sharps Compliance offers comprehensive solutions for the management of regulated medical waste, hazardous waste and unused medications.

HOUSTON, June 16, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive Officer, will participate in the ROTH Virtual London Conference on Tuesday, June 22, 2021. He will conduct one-on-one meetings throughout the day.

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps Compliance (NASDAQ: SMED) is a leading business-to-business services provider to the healthcare, long-term care and retail pharmacy markets. Sharps Compliance offers comprehensive solutions for the management of regulated medical waste, hazardous waste and unused medications. For more information, visit: www.sharpsinc.com.

Company Contact:	Diana Diaz
	Sharps Compliance Corp.
	Email: [email protected]
	Office: (713) 660-3547

Investor Contact:	John Nesbett/Jennifer Belodeau
	Institutional Marketing Services
	Email: [email protected]
	Office: (203) 972-9200